Clinical Benefit-Risk Profile of Lenalidomide in Patients With Lower-Risk Myelodysplastic Syndromes Without Del(5Q): Results of a Phase Iii Trial

AuthID
 P-015-B3H
9
Author(s)
Garcia-Manero, G
·
Fenaux, P
·
Gattermann, N
·
Giagounidis, A
·
Goldberg, SL
·
Ozawa, K
·
Weaver, J
·
Santini, V
Document Type
Article
Year published
2019
Published
in Clinical Lymphoma Myeloma and Leukemia, ISSN: 2152-2650
Volume: 19, Issue: 4, Pages: 213-219.e4
Indexing
Crossref®4
Google Scholar®
Publication Identifiers
Source Identifiers
ISSN: 2152-2650
Export Publication Metadata
Marked List
 Add to Marked List
Info
At this moment we don't have any links to full text documens.

footer slogan

Useful Links

Get Help

© 2024 CRACS & Inesc TEC - All Rights Reserved Privacy Policy | Terms of Service